Corcept Therapeutics Incorporated shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $24M | 934k | 25.19 |
| 2023-12-31 | $29M | 900k | 32.48 |
| 2023-09-30 | $24M | 861k | 27.25 |
| 2023-06-30 | $19M | 844k | 22.25 |
| 2023-03-31 | $19M | 890k | 21.66 |
| 2022-12-31 | $18M | 890k | 20.31 |
| 2022-09-30 | $21M | 823k | 25.64 |
| 2022-06-30 | $19M | 815k | 23.78 |
| 2022-03-31 | $18M | 786k | 22.52 |
| 2021-12-31 | $14M | 680k | 19.80 |
| 2021-09-30 | $15M | 765k | 19.68 |
| 2021-06-30 | $17M | 766k | 22.00 |
| 2021-03-31 | $19M | 790k | 23.79 |
| 2020-12-31 | $20M | 764k | 26.16 |
| 2020-09-30 | $13M | 750k | 17.41 |
| 2020-06-30 | $13M | 766k | 16.82 |
| 2020-03-31 | $8.2M | 691k | 11.89 |
| 2019-12-31 | $8.3M | 687k | 12.10 |
| 2019-09-30 | $8.5M | 600k | 14.14 |
| 2019-06-30 | $6.6M | 592k | 11.15 |
| 2019-03-31 | $6.8M | 582k | 11.74 |
| 2018-12-31 | $7.5M | 562k | 13.36 |
| 2018-09-30 | $7.9M | 562k | 14.02 |
| 2018-06-30 | $7.9M | 502k | 15.72 |
| 2018-03-31 | $8.1M | 491k | 16.45 |
| 2017-12-31 | $8.7M | 481k | 18.06 |
| 2017-09-30 | $8.0M | 414k | 19.30 |
| 2017-06-30 | $4.4M | 371k | 11.80 |
| 2017-03-31 | $3.7M | 340k | 10.96 |
| 2016-12-31 | $2.3M | 321k | 7.26 |
| 2016-09-30 | $1.8M | 279k | 6.50 |
| 2016-06-30 | $640k | 117k | 5.47 |
| 2016-03-31 | $405k | 87k | 4.68 |
| 2015-12-31 | $431k | 87k | 4.98 |
| 2015-09-30 | $326k | 87k | 3.77 |
| 2015-06-30 | $520k | 87k | 6.01 |
| 2015-03-31 | $384k | 68k | 5.61 |
| 2014-12-31 | $206k | 68k | 3.01 |
| 2014-09-30 | $184k | 68k | 2.69 |
| 2014-06-30 | $192k | 68k | 2.81 |
| 2014-03-31 | $299k | 68k | 4.37 |
| 2013-12-31 | $221k | 68k | 3.23 |
| 2013-09-30 | $111k | 68k | 1.62 |
| 2013-06-30 | $122k | 68k | 1.78 |
| 2013-03-31 | $131k | 68k | 1.92 |
| 2012-12-31 | $98k | 68k | 1.43 |
| 2012-09-30 | $189k | 68k | 2.76 |
| 2012-06-30 | $236k | 55k | 4.29 |
| 2012-03-31 | $223k | 55k | 4.05 |
| 2011-12-31 | $189k | 55k | 3.44 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated